bullish
Shanghai Henlius Biotech IPO Initiation: Going Large
648 Views21 Aug 2019 02:46
Shanghai Henlius Biotech (1566213D HK) is a biopharmaceutical company and a non-wholly owned subsidiary of Shanghai Fosun Pharmaceutical (Group)...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 11-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Peloton Interactive IPO Preview02 Sep 2019
- Peloton IPO Preview: Riding into Your Home28 Aug 2019
- Shanghai Henlius Biotech IPO: Cash Breakeven Analysis26 Aug 2019
- Shanghai Henlius Biotech IPO Initiation: Going Large21 Aug 2019
- Venus Medtech IPO Initiation: The Heart of the Business12 Aug 2019
x